EU RESEARCH PROJECT IDENTIFIES NEW WAYS OF TREATING ASTHMA
October 1st, 2010
BY KEITH NUTHALL
A NEW approach to developing asthma medication has been identified by a European Union (EU)-funded research project: target the condition's genetic root causes, not just allergies prompting symptoms. The Euro 11 million GABRIEL project, Professor Miriam Moffatt, of Imperial College London, told a European Commission briefing note, means "we now know that allergies may develop as a result of defects of the lining of the airways in asthma," so "concentrating therapies only on allergy will not effectively treat the whole ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.